Abstract
Medullomyoblastoma is a rare embryonal tumor of the central nervous system and is classified as medulloblastoma with myogenic differentiation according to the most recent WHO classification, 4th edition. The tumor cells have neuroectodermal and myoblastic features. The origin of the myoblastic element of MMB remains to be completely clarified. We reported a case of a 3-year-old girl with medullomyoblastoma in the cerebellar vermis. She underwent total resection of the tumor, followed by chemotherapy and radiotherapy in the brain and spinal cord. The resected specimen mainly consisted of densely packed cells with round-to-oval highly chromatic nuclei surrounded by scanty cytoplasm (indicating neuroectodermal differentiation) and focally of long spindle-shaped cells with elongated nuclei and eosinophilic cytoplasm showing discernible cross-striations (indicating myoblastic differentiation). In addition, the tumor cells showed large nuclei with nucleolus, frequent mitoses, apoptoses, nuclear molding, and cell wrapping, indicating moderate anaplasia. Immunohistochemical staining revealed partial expression of myoglobin and desmin as well as synaptophysin and neurofilament in the tumor cells. Some tumor cells showed double immunopositivity for synaptophysin and myoglobin, suggesting the idea that the neuroectodermal cells may undergo differentiation into rhabdomyoblasts.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blanc E, Goldschneider D, Douc-Rasy S, Benard J, Raguenez G (2005) Wnt-5a gene expression in malignant human neuroblasts. Cancer Lett 228: 117–123
Carlotti CG Jr, Smith C, Rutka JT (2008) The molecular genetics of medulloblastoma: an assessment of new therapeutic targets. Neurosurg Rev 31:359–368
Eberhart CG, Kepner JL, Goldtheaite PT, Kun LE, Duffner PK, Friedman HS, Strother DR, Burger PC (2002) Histopathologic grading of medulloblastomas: a pediatric oncology group study. Cancer 94:552–560
Er U, Yigitkanli K, Kazanci B, Ozturk E, Sorar M, Bavbek M (2008) Medullomyoblastoma: teratoid nature of a quite rare neoplasm. Surg Neurol 69:403–406
Fan X, Eberhart CG (2008) Medulloblastoma stem cells. J Clin Oncol 26:2821–2827
Giangaspero F, Eberhart CG, Haapasalo H, Pietsch T, Wiestler OD, Ellison DW (2007) Medulloblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) World Health Organization classification of tumours of the central nervous system. IARC Press, Lyon, pp 132–140
Giordana M, Wiestler OD (2000) Medullomyoblastoma. In: Kleihues P, Cavenee WK (eds) World Health Organization classification of tumours, pathology and genetics of tumours of the nervous system. IARC Press, Lyon, pp 138–139
Helton KJ, Fouladi M, Boop FA, Perry A, Dalton J, Kun L, Fuller C (2004) Medullomyoblastoma: a radiographic and clinicopathologic analysis of six cases and review of the literature. Cancer 101:1445–1454
Ingraham F, Bailey O (1946) Cystic teratomas and teratoid tumors of the central nervous system in infancy and childhood. J Neurosurg 3:511–532
Jaiswal AK, Jaiswal S, Mahapatra AK, Sharma MC (2005) Unusually long survival in a case of medullomyoblastoma. J Clin Neurosci 12:961–963
Kido M, Ueno M, Onodera M, Matsumoto K, Imai T, Haba R, Tamiya T, Huang C, Sakamoto H (2009) Medulloblastoma with myogenic differentiation showing double immunopositivity for synaptophysin and myoglobin. Pathol Int 59:255–260
Lindberg E, Persson A, Ora I, Mertens F, Englund E, Gisselsson D (2007) Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma. NeuroÂpathology 27:556–560
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 114:97–109
Mahapatra AK, Sinha AK, Sharma MC (1998) MedulloÂmyoblastoma. A rare cerebellar tumour in children. Childs Nerv Syst 14:312–316
Marinesco G, Goldstein M (1933) On an anatomical form of medulloblastoma not yet described, medullomyoblastoma. Ann Anat Pathol (Paris) 10:513–525
Meurer RT, Martins DT, Hilbig A, Ribeiro MC, Roehe AV, Narbosa-Coutinho LM, Fernandes MC (2008) Immunohistochemical expression of markers Ki-67, NeuN, synaptophysin, p53 and HER2 in medulloblastoma and its correlation with clinicopathological parameters. Arq Neuropsiquiatr 66:385–390
Min HS, Lee YJ, Park K, Cho B-K, Park S-H (2006) Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior. Acta Neuropathol 112:13–20
Shintaku M, Ogura M, Maeda R, Nishiyama T (1982) An autopsy case of medulloblastoma. Brain Nerve 34:105–114
Smith TW, Davidson RI (1984) Medulloblastoma. A histologic, immunohistochemical, and ultrastructural study. Cancer 54:323–332
Stahlberger R, Friede RL (1977) Fine structure of myomedulloblastoma. Acta Neuropathol 37:43–48
Walter GF, Brucher JM (1979) Ultrastructural study of medullomyoblastoma. Acta Neuropathol 48:211–214
Yokota N, Daniels F, Crosson J, Rabb H (2002) Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer 101:198–201
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Ueno, M., Onodera, M., Kusaka, T., Haba, R., Tamiya, T., Sakamoto, H. (2012). Pediatric Medullomyoblastoma: Immunohistochemical Analyses. In: Hayat, M. (eds) Pediatric Cancer, Volume 3. Pediatric Cancer, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4528-5_17
Download citation
DOI: https://doi.org/10.1007/978-94-007-4528-5_17
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4527-8
Online ISBN: 978-94-007-4528-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)